Delving into the Latest Updates on PT-061 with Synapse

Overview

Basic Info

Drug Type

Monoclonal antibody

Synonyms

Target-

Action-

Mechanism-

Therapeutic Areas

NeoplasmsRespiratory Diseases

Active Indication-

Inactive Indication

Lung Cancer

Originator Organization

Perseus Proteomics, Inc.

Active Organization-

Inactive Organization

Perseus Proteomics, Inc.

License Organization-

Drug Highest PhaseDiscontinuedDiscovery

First Approval Date-

Regulation-

Selective glycosylation of "prompt" stress glycoproteins (P-SG), mainly P-SG67 and P-SG64 (M(r) of 64,000, pI = 5.1), occurs immediately during acute heat-stress. In the present study, P-SG64 was purified by sequential gel filtration, anion-exchange, affinity chromatography, and two-dimensional isoelectric focusing/SDS-PAGE. Purified P-SG64 was further characterized by microsequencing of a peptide fragment, PT-61, which showed a 100% sequence homology with calreticulin, suggesting that P-SG64 is identical to calreticulin. PT-61 also showed 55%, 58% and 63% sequence homologies with calnexin, HIV-1 gp120 and HIV-2 envelope polyprotein, respectively. 45Ca2+ overlay studies confirmed Ca(2+)-binding of P-SG64. P-SG67 was also recently identified as calreticulin (8), which suggests that CHO cells either have two isoforms of calreticulin or express variable states of calreticulin glycosylation during acute heat stress. The role of intracellular Ca2+ ([Ca2+]i) during heat-induced "prompt" glycosylation was also examined and indicated an 8-fold increase in [Ca2+]i. Chelation of this increased cytoplasmic Ca2+ by BAPTA reduced glycosylation of P-SG67/P-SG64/calreticulin only by approximately 20%. This observation suggests that altered [Ca2+]i homeostasis is not directly linked to calreticulin glycosylation, instead, heat-induced calreticulin glycosylation is a Ca(2+)-independent effect.

100 Deals associated with PT-061

Login to view more data

R&D Status

10 top R&D records.

Login

to view more data

Indication	Highest Phase	Country/Location	Organization	Date
Lung Cancer	Discovery	Japan	Perseus Proteomics, Inc.	-

Login to view more data

Clinical Result

Indication

Phase

Evaluation

View All Results

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.

login

or

view full example data

Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.

login

or

view full example data

Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.

login

or

view full example data

Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.

login

or

view full example data

Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.

login

or

view full example data

Accelerate your research with the latest regulatory approval information.

Biosimilar

Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.

login

or

view full example data